LigronBio develops biotech solutions, focusing on molecular glue-based targeted therapeutics and computational chemistry.
LigronBio is headquartered in Newark, United States.
LigronBio develops biotech solutions, focusing on molecular glue-based targeted therapeutics and computational chemistry.
LigronBio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LigronBio — Funding & Investors." VCBacked, February 12, 2026, https://www.vcbacked.co/company/ligronbio. Accessed July 19, 2026.
VCBacked. (2026). LigronBio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/ligronbio
{{cite web |title=LigronBio — Funding & Investors |url=https://www.vcbacked.co/company/ligronbio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated